id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-V-1596-0001,FDA,FDA-2013-V-1596,Duality- Application for Variance,Other,Application for Variance (VAR),2013-12-31T05:00:00Z,2013,12,2013-12-31T05:00:00Z,,2013-12-31T18:19:11Z,,0,0,09000064814b23ab
FDA-2011-N-0922-0017,FDA,FDA-2011-N-0922,Request for Extension from American Feed Industry Association,Other,Request for Extension,2013-12-31T05:00:00Z,2013,12,2013-12-31T05:00:00Z,,2013-12-31T19:44:06Z,,0,0,0900006481492bbf
FDA-2013-V-1595-0001,FDA,FDA-2013-V-1595,Create Nightclub - Application for Variance,Other,Application for Variance (VAR),2013-12-31T05:00:00Z,2013,12,2013-12-31T05:00:00Z,,2013-12-31T18:24:52Z,,0,0,09000064814b34bd
FDA-1979-N-0028-0036,FDA,FDA-1979-N-0028,Letter from SunChemical Corporation to FDA Dated March 20 1997,Other,Letter(s),2013-12-31T05:00:00Z,2013,12,1998-04-15T04:00:00Z,,2015-04-01T19:48:32Z,,0,0,090000648055399b
FDA-2013-V-1596-0002,FDA,FDA-2013-V-1596,Acknowledgement Letter to Duality,Other,Acknowledgement Letter/Receipt,2013-12-31T05:00:00Z,2013,12,2013-12-31T05:00:00Z,,2013-12-31T18:19:19Z,,0,0,09000064814b34bb
FDA-2013-V-1595-0002,FDA,FDA-2013-V-1595,Acknowledgement Letter to Create Nightclub,Other,Acknowledgement Letter/Receipt,2013-12-31T05:00:00Z,2013,12,2013-12-31T05:00:00Z,,2013-12-31T18:25:02Z,,0,0,09000064814b34bf
FDA-2013-V-1607-0001,FDA,FDA-2013-V-1607,DJ Leo Entertainment - Application for Variance,Other,Application for Variance (VAR),2013-12-30T05:00:00Z,2013,12,2013-12-30T05:00:00Z,,2013-12-30T15:50:09Z,,0,0,09000064814baabb
FDA-2013-V-1608-0002,FDA,FDA-2013-V-1608,Acknowledgement Letter to Nu-Salt,Other,Acknowledgement Letter/Receipt,2013-12-30T05:00:00Z,2013,12,2013-12-30T05:00:00Z,,2013-12-30T15:10:14Z,,0,0,09000064814ba667
FDA-2013-P-1611-0002,FDA,FDA-2013-P-1611,Acknowledgement Letter to Clarissa Clarke,Other,Acknowledgement Letter/Receipt,2013-12-30T05:00:00Z,2013,12,2013-12-30T05:00:00Z,,2024-07-25T12:19:07Z,,0,0,09000064814ba8c7
FDA-2013-V-1599-0001,FDA,FDA-2013-V-1599,The Living Room - Application for Variance,Other,Application for Variance (VAR),2013-12-30T05:00:00Z,2013,12,2013-12-30T05:00:00Z,,2013-12-30T14:58:50Z,,0,0,09000064814b6fb0
FDA-2013-V-1599-0002,FDA,FDA-2013-V-1599,Acknowledgement Letter to The Living Room,Other,Acknowledgement Letter/Receipt,2013-12-30T05:00:00Z,2013,12,2013-12-30T05:00:00Z,,2013-12-30T14:58:51Z,,0,0,09000064814b6ff2
FDA-2013-V-1607-0002,FDA,FDA-2013-V-1607,Acknowledgement Letter to DJ Leo Entertainment,Other,Acknowledgement Letter/Receipt,2013-12-30T05:00:00Z,2013,12,2013-12-30T05:00:00Z,,2013-12-30T15:50:09Z,,0,0,09000064814baabd
FDA-2013-V-1608-0001,FDA,FDA-2013-V-1608,Nu-Salt - Application for Variance,Other,Application for Variance (VAR),2013-12-30T05:00:00Z,2013,12,2013-12-30T05:00:00Z,,2013-12-30T15:10:13Z,,0,0,09000064814ba665
FDA-2013-P-1609-0001,FDA,FDA-2013-P-1609,"Lachman Consultant Services, Inc. - Citizen Petition",Other,Citizen Petition,2013-12-30T05:00:00Z,2013,12,2013-12-30T05:00:00Z,,2024-11-07T22:59:08Z,,1,0,09000064814ba5ba
FDA-2013-P-1623-0001,FDA,FDA-2013-P-1623,"Sigmapharm Laboratories, LLC - Citizen Petition",Other,Citizen Petition,2013-12-30T05:00:00Z,2013,12,2013-12-30T05:00:00Z,,2019-07-08T13:35:40Z,,0,0,09000064814bd194
FDA-2013-P-1623-0002,FDA,FDA-2013-P-1623,Acknowledgement Letter to Sigmapharm Laboratories LLC,Other,Acknowledgement Letter/Receipt,2013-12-30T05:00:00Z,2013,12,2013-12-30T05:00:00Z,,2013-12-30T16:12:16Z,,0,0,09000064814bd198
FDA-2013-N-1425-0003,FDA,FDA-2013-N-1425,List of References From PRIA Reference 65,Other,List (LST),2013-12-30T05:00:00Z,2013,12,2013-12-30T05:00:00Z,,2013-12-30T14:09:49Z,,0,0,09000064814e179f
FDA-2013-P-1609-0002,FDA,FDA-2013-P-1609,"Acknowledgement Letter to Lachman Consultant Services, Inc.",Other,Citizen Petition,2013-12-30T05:00:00Z,2013,12,2013-12-30T05:00:00Z,,2013-12-30T16:00:10Z,,0,0,09000064814ba662
FDA-1979-N-0084-0004,FDA,FDA-1979-N-0084,Memorandum from FDA CFSAN to DDM,Other,Memorandum,2013-12-30T05:00:00Z,2013,12,,,2014-05-12T18:38:57Z,,0,0,0900006480553e85
FDA-2013-P-1611-0001,FDA,FDA-2013-P-1611,Citizen Petition from Clarissa Clarke,Other,Citizen Petition,2013-12-30T05:00:00Z,2013,12,2013-12-30T05:00:00Z,,2024-07-25T12:18:51Z,,0,0,09000064814ba6d2
FDA-1977-N-0005-0367,FDA,FDA-1977-N-0005,"FDA/Office of Legislative Affairs to Hess & Clark, Inc. - Answer",Other,Answer,2013-12-27T05:00:00Z,2013,12,2013-12-27T05:00:00Z,,2013-12-27T15:16:38Z,,0,0,09000064805d7d65
FDA-2011-P-0438-0006,FDA,FDA-2011-P-0438,FDA/CDRH Response to Public Citizen Health Research Group - Partial Petition Approval and Denial,Other,Partial Petition Approval and Denial,2013-12-27T05:00:00Z,2013,12,2013-12-27T05:00:00Z,,2013-12-27T12:55:24Z,,0,0,09000064814ddf89
FDA-1977-N-0005-0385,FDA,FDA-1977-N-0005,FDA/Office of Legislative Affairs to Cooper Evans  - Answer,Other,Answer,2013-12-27T05:00:00Z,2013,12,2013-12-27T05:00:00Z,,2013-12-27T16:52:54Z,,0,0,09000064805d7d66
FDA-1977-N-0005-0366,FDA,FDA-1977-N-0005,"Department of Health & Human Services, Public Health Service, Region 5 - Letter",Other,Letter(s),2013-12-27T05:00:00Z,2013,12,2013-12-27T05:00:00Z,,2013-12-27T15:11:24Z,,0,0,09000064805d7b8f
FDA-2013-M-1605-0001,FDA,FDA-2013-M-1605,"Premarket Approval of W.L. Gore and Associates, Inc. P130006",Other,Approval,2013-12-26T05:00:00Z,2013,12,2013-12-26T05:00:00Z,,2013-12-26T15:12:16Z,,0,0,09000064814dab0f
FDA-2013-E-1694-0002,FDA,FDA-2013-E-1694,"TriVascular, Inc. - Patent Term Application",Other,Application,2013-12-26T05:00:00Z,2013,12,2013-12-26T05:00:00Z,,2013-12-26T17:49:36Z,,0,0,09000064814dd643
FDA-2013-E-1694-0001,FDA,FDA-2013-E-1694,U.S. Patant and Trademark Office - Letter,Other,Letter(s),2013-12-26T05:00:00Z,2013,12,2013-12-26T05:00:00Z,,2013-12-26T17:49:28Z,,0,0,09000064814dd644
FDA-2013-E-1691-0001,FDA,FDA-2013-E-1691,U.S.. Patatent and Trademark Office - Letter,Other,Letter(s),2013-12-26T05:00:00Z,2013,12,2013-12-26T05:00:00Z,,2013-12-26T14:10:36Z,,0,0,09000064814dc7e9
FDA-2013-D-1566-0002,FDA,FDA-2013-D-1566,Draft Guidance for Industry on Naming of Drug Products Containing Salt Drug Substances,Other,Guidance,2013-12-26T05:00:00Z,2013,12,2013-12-26T05:00:00Z,,2024-11-07T23:00:18Z,,1,0,09000064814dcd46
FDA-2013-E-1692-0001,FDA,FDA-2013-E-1692,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2013-12-26T05:00:00Z,2013,12,2013-12-26T05:00:00Z,,2013-12-26T14:45:07Z,,0,0,09000064814dc7ee
FDA-2013-E-0296-0003,FDA,FDA-2013-E-0296,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2013-12-26T05:00:00Z,2013,12,2013-12-26T05:00:00Z,,2013-12-26T15:48:59Z,,0,0,09000064814dcd48
FDA-1977-N-0005-0329,FDA,FDA-1977-N-0005,FDA/Office of Legislative Affairs to the Honorable Paul Findley  - Comment,Other,Answer,2013-12-26T05:00:00Z,2013,12,2013-12-26T05:00:00Z,,2013-12-26T18:05:15Z,,0,0,09000064805d7d64
FDA-2013-E-1691-0002,FDA,FDA-2013-E-1691,"Morrison & Foerster LLP (on behalf of Genenetech, Inc) - Patent Term Application",Other,Application,2013-12-26T05:00:00Z,2013,12,2013-12-26T05:00:00Z,,2013-12-26T14:27:36Z,,0,0,09000064814db700
FDA-2013-E-1690-0002,FDA,FDA-2013-E-1690,"CEPHALON, Inc. -  Patent Term Application",Other,Application,2013-12-26T05:00:00Z,2013,12,2013-12-26T05:00:00Z,,2013-12-26T13:38:09Z,,0,0,09000064814db6fc
FDA-2013-E-1692-0002,FDA,FDA-2013-E-1692,"Morrison & Foerster LLP (on behalf of Genenetech, Inc) - Patent Term Application",Other,Application,2013-12-26T05:00:00Z,2013,12,2013-12-26T05:00:00Z,,2013-12-26T14:45:22Z,,0,0,09000064814dc7ed
FDA-2013-E-1690-0001,FDA,FDA-2013-E-1690,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2013-12-26T05:00:00Z,2013,12,2013-12-26T05:00:00Z,,2013-12-26T13:38:00Z,,0,0,09000064814db6fd
FDA-2009-E-0087-0013,FDA,FDA-2009-E-0087,U.S. Patent and Trademark Office to Zoetis - Letter,Other,Letter(s),2013-12-24T05:00:00Z,2013,12,2013-12-24T05:00:00Z,,2013-12-24T13:04:38Z,,0,0,09000064814d407b
FDA-2013-V-1559-0002,FDA,FDA-2013-V-1559,"Acknowledgement Letter to Coast Digital Solutions, Inc.",Other,Acknowledgement Letter/Receipt,2013-12-24T05:00:00Z,2013,12,2013-12-24T05:00:00Z,,2013-12-24T18:13:20Z,,0,0,09000064814a5fa4
FDA-2013-V-1559-0001,FDA,FDA-2013-V-1559,"Coast Digital Solutions, Inc. - Application for Variance",Other,Application for Variance (VAR),2013-12-24T05:00:00Z,2013,12,2013-12-24T05:00:00Z,,2013-12-24T18:13:19Z,,0,0,09000064814a5f9f
FDA-2013-E-0682-0004,FDA,FDA-2013-E-0682,U.S. Patent and Trademark Office to Venable LLP - Letter,Other,Letter(s),2013-12-24T05:00:00Z,2013,12,2013-12-24T05:00:00Z,,2013-12-24T13:23:43Z,,0,0,09000064814d407d
FDA-2013-V-1560-0002,FDA,FDA-2013-V-1560,Acknowledgement Letter to Davaine Lighting,Other,Acknowledgement Letter/Receipt,2013-12-24T05:00:00Z,2013,12,2013-12-24T05:00:00Z,,2013-12-24T18:19:41Z,,0,0,09000064814a5c89
FDA-2013-V-1560-0001,FDA,FDA-2013-V-1560,Davaine Lighting - Application for Variance,Other,Application for Variance (VAR),2013-12-24T05:00:00Z,2013,12,2013-12-24T05:00:00Z,,2013-12-24T18:19:25Z,,0,0,09000064814a5c85
FDA-2013-P-0380-0003,FDA,FDA-2013-P-0380,FDA/CDER Interim Response to the University of Florida College of Medicine - Jacksonville and the UNC School of Medicine - Letter,Other,Letter(s),2013-12-24T05:00:00Z,2013,12,2013-12-24T05:00:00Z,,2015-07-07T22:14:36Z,,0,0,09000064814414e8
FDA-2011-P-0086-0006,FDA,FDA-2011-P-0086,"Janssen Research & Development, LLC. - Supplement",Other,Supplement (SUP),2013-12-24T05:00:00Z,2013,12,2013-12-24T05:00:00Z,,2013-12-24T20:07:39Z,,0,0,09000064814ba9d1
FDA-2012-N-0284-0009,FDA,FDA-2012-N-0284,FDA CDER Memorandum December 17 2013 re for use of Sodium Nitroprusside to Reduce Blood Pressure  in Pediatric Patients,Other,Memorandum,2013-12-24T05:00:00Z,2013,12,2013-12-24T05:00:00Z,,2013-12-24T13:59:09Z,,0,0,09000064814d51b8
FDA-2012-P-0052-0004,FDA,FDA-2012-P-0052,"FDA/CDER Response to Lannett Company, Inc. - Petition Denial",Other,Denial,2013-12-23T05:00:00Z,2013,12,2013-12-23T05:00:00Z,,2013-12-23T17:11:56Z,,0,0,09000064814d358c
FDA-1975-N-0012-0320,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re Chain Drug Chain Drug Consortium Beijing China,Other,Letter(s),2013-12-23T05:00:00Z,2013,12,2013-12-23T05:00:00Z,,2014-01-05T03:25:12Z,,0,0,09000064814b004f
FDA-2007-P-0346-0054,FDA,FDA-2007-P-0346,"Richard Sauerheber, Ph.D. - Letter",Other,Letter(s),2013-12-23T05:00:00Z,2013,12,2013-12-23T05:00:00Z,,2014-11-17T16:59:47Z,,0,0,09000064814a685a
FDA-2013-P-1641-0002,FDA,FDA-2013-P-1641,Acknowledgement Letter to TEVA Pharmaceuticals,Other,Acknowledgement Letter/Receipt,2013-12-23T05:00:00Z,2013,12,2013-12-12T05:00:00Z,,2013-12-23T15:14:12Z,,0,0,09000064814c457d
FDA-2013-P-0848-0003,FDA,FDA-2013-P-0848,"FDA/CDER Response to Hyman, Phelps & McNamara, P.C. - Petition Approval",Other,Approval,2013-12-23T05:00:00Z,2013,12,2013-12-23T05:00:00Z,,2013-12-23T17:24:35Z,,0,0,09000064814d2a67
FDA-2013-P-0849-0003,FDA,FDA-2013-P-0849,"FDA/CDER Response to Hyman, Phelps & McNamara, P.C. - Petition Approval",Other,Approval,2013-12-23T05:00:00Z,2013,12,2013-12-23T05:00:00Z,,2013-12-23T13:24:41Z,,0,0,09000064814d2a69
FDA-1975-N-0012-0318,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re Certus Medical  Inc,Other,Letter(s),2013-12-23T05:00:00Z,2013,12,2013-12-23T05:00:00Z,,2014-01-05T03:25:12Z,,0,0,09000064814b004d
FDA-1975-N-0012-0321,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re Chain Drug Chain Drug Consortium Shanghai China,Other,Letter(s),2013-12-23T05:00:00Z,2013,12,2013-12-23T05:00:00Z,,2014-01-05T03:25:12Z,,0,0,09000064814b0050
FDA-2013-P-1612-0055,FDA,FDA-2013-P-1612,Acknowledgement Letter from FDA/DDM to Gary Head and Partners,Other,Acknowledgement Letter/Receipt,2013-12-23T05:00:00Z,2013,12,2013-12-16T05:00:00Z,,2014-10-01T15:52:48Z,,0,0,09000064814c46ee
FDA-2011-P-0610-0005,FDA,FDA-2011-P-0610,AbbVie Inc. (Hogan Lovells) - Supplement,Other,Supplement (SUP),2013-12-23T05:00:00Z,2013,12,2013-12-23T05:00:00Z,,2013-12-23T17:55:57Z,,0,0,09000064814bb904
FDA-1975-N-0012-0319,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re Chain Drug Constortium Israel,Other,Letter(s),2013-12-23T05:00:00Z,2013,12,2013-12-23T05:00:00Z,,2014-01-05T03:25:12Z,,0,0,09000064814b004e
FDA-2013-P-1612-0057,FDA,FDA-2013-P-1612,"Acknowledgement Letter from FDA/DDM to Tom Hitchcock, R. D.",Other,Acknowledgement Letter/Receipt,2013-12-23T05:00:00Z,2013,12,2013-12-23T05:00:00Z,,2014-10-01T16:04:42Z,,0,0,09000064814c46f0
FDA-2011-N-0920-0411,FDA,FDA-2011-N-0920,Record of Outreach Session from FDA/CFSAN,Other,Electronic Regulation from Form,2013-12-23T05:00:00Z,2013,12,2013-08-09T04:00:00Z,2013-11-23T04:59:59Z,2014-02-28T17:39:43Z,,0,0,09000064814758d5
FDA-2013-P-1612-0053,FDA,FDA-2013-P-1612,Acknowledgement Letter from FDA/DDM to Allen Seto,Other,Acknowledgement Letter/Receipt,2013-12-23T05:00:00Z,2013,12,2013-12-23T05:00:00Z,,2014-10-01T15:44:01Z,,0,0,09000064814c46ec
FDA-1977-N-0005-0079,FDA,FDA-1977-N-0005,Answer from FDA to Comment from Animal Health Institute,Other,Answer,2013-12-20T05:00:00Z,2013,12,2013-12-20T05:00:00Z,,2018-12-10T18:39:32Z,,0,0,09000064805d7d61
FDA-1977-N-0005-0080,FDA,FDA-1977-N-0005,Answer from FDA to Comment from the United States Congressman Dan Coats,Other,Answer,2013-12-20T05:00:00Z,2013,12,,,2018-12-10T18:54:44Z,,0,0,09000064805d7d62
FDA-1977-N-0005-0065,FDA,FDA-1977-N-0005,FDA/Office of Legislative Services to the Honorable Steve Symms - Answer,Other,Answer,2013-12-20T05:00:00Z,2013,12,2013-12-20T05:00:00Z,,2013-12-20T15:00:43Z,,0,0,09000064805d7d60
FDA-2013-E-1657-0001,FDA,FDA-2013-E-1657,"Aegerion Pharmacueticals, Inc. (Goodwin Procter LLP) - Paatent Term Application",Other,Application,2013-12-19T05:00:00Z,2013,12,2013-12-19T05:00:00Z,,2013-12-19T12:47:13Z,,0,0,09000064814ca53a
FDA-2013-V-1453-0001,FDA,FDA-2013-V-1453,XrossPoint LLC - Application for Variance,Other,Application for Variance (VAR),2013-12-19T05:00:00Z,2013,12,2013-12-19T05:00:00Z,,2013-12-19T20:55:55Z,,0,0,0900006481486fad
FDA-2013-V-1471-0002,FDA,FDA-2013-V-1471,Acknowledgement Letter to 515 Entertainment Group,Other,Acknowledgement Letter/Receipt,2013-12-19T05:00:00Z,2013,12,2013-12-19T05:00:00Z,,2013-12-19T20:58:58Z,,0,0,090000648148bb93
FDA-2013-P-0850-0003,FDA,FDA-2013-P-0850,Citizen Petition Partial Approval and Denial Response from FDA CDER to  TEVA Pharmaceuticals,Other,Letter(s),2013-12-19T05:00:00Z,2013,12,2013-12-19T05:00:00Z,,2013-12-19T12:08:41Z,,0,0,09000064814caa74
FDA-2013-V-1471-0001,FDA,FDA-2013-V-1471,515 Entertainment Group - Application for Variance,Other,Application for Variance (VAR),2013-12-19T05:00:00Z,2013,12,2013-12-19T05:00:00Z,,2013-12-19T20:57:54Z,,0,0,090000648148b7f7
FDA-2013-E-1657-0002,FDA,FDA-2013-E-1657,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2013-12-19T05:00:00Z,2013,12,2013-12-19T05:00:00Z,,2013-12-19T12:47:25Z,,0,0,09000064814ca53b
FDA-2013-P-1000-0003,FDA,FDA-2013-P-1000,Citizen Petition Denial Response from FDA CDER to Eclat Pharmaceutical LLC  Patton Boggs,Other,Denial,2013-12-19T05:00:00Z,2013,12,2013-12-19T05:00:00Z,,2013-12-19T12:46:44Z,,0,0,09000064814caa76
FDA-2013-V-1453-0002,FDA,FDA-2013-V-1453,Acknowledgemnet Letter to XrossPoint LLC,Other,Acknowledgement Letter/Receipt,2013-12-19T05:00:00Z,2013,12,2013-12-19T05:00:00Z,,2013-12-19T20:56:34Z,,0,0,0900006481486fb0
FDA-2013-E-1652-0001,FDA,FDA-2013-E-1652,"Heartware, Inc. (Coopper & Dunham, LLP) Patent Term Application",Other,Application,2013-12-18T05:00:00Z,2013,12,2013-12-18T05:00:00Z,,2013-12-18T20:26:10Z,,0,0,09000064814c9629
FDA-2013-P-1374-0003,FDA,FDA-2013-P-1374,"Supplement from Pharmacists Planning Service, Inc.",Other,Supplement (SUP),2013-12-18T05:00:00Z,2013,12,2013-12-18T05:00:00Z,,2015-07-21T14:30:50Z,,0,0,09000064814ae187
FDA-2013-E-1652-0002,FDA,FDA-2013-E-1652,U.S. Patent and Trademark Office Letter,Other,Letter(s),2013-12-18T05:00:00Z,2013,12,2013-12-18T05:00:00Z,,2013-12-22T04:00:45Z,,0,0,09000064814ca31b
FDA-2013-E-1656-0002,FDA,FDA-2013-E-1656,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2013-12-18T05:00:00Z,2013,12,2013-12-18T05:00:00Z,,2013-12-18T20:59:39Z,,0,0,09000064814ca381
FDA-2013-E-1656-0001,FDA,FDA-2013-E-1656,Pfizer Inc. -  Patent Term Application,Other,Application,2013-12-18T05:00:00Z,2013,12,2013-12-18T05:00:00Z,,2013-12-18T21:06:55Z,,0,0,09000064814ca380
FDA-2013-P-1612-0013,FDA,FDA-2013-P-1612,Citizen Petition from Edith Hoechst,Other,Citizen Petition,2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,2014-06-13T03:59:59Z,2015-09-23T13:28:32Z,,0,0,09000064814c46ae
FDA-2013-P-1612-0012,FDA,FDA-2013-P-1612,Acknowledgement Letter from FDA/DDM to U. S. I. Insurance Services,Other,Acknowledgement Letter/Receipt,2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,,2014-10-01T12:53:07Z,,0,0,09000064814c46ad
FDA-1994-V-0006-0007,FDA,FDA-1994-V-0006,FDA/CDRH Response to Surefire LLC - Approval of Variance,Other,Approval for Variance (VRA),2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,,2013-12-17T14:22:25Z,,0,0,09000064814bb97e
FDA-2013-P-1612-0003,FDA,FDA-2013-P-1612,Citizen Petition from Lisa Hoechst,Other,Citizen Petition,2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,2014-06-12T03:59:59Z,2015-09-23T13:25:15Z,,0,0,09000064814c457f
FDA-2013-P-1612-0011,FDA,FDA-2013-P-1612,Citizen Petition from Philip Remig USI Insurance Services  re EPA Drug Initiative,Other,Citizen Petition,2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,2014-06-13T03:59:59Z,2015-09-23T13:28:06Z,,0,0,09000064814c46ac
FDA-2013-P-1612-0009,FDA,FDA-2013-P-1612,Citizen Petition from Lee Robertson,Other,Citizen Petition,2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,2014-06-13T03:59:59Z,2015-09-23T13:27:38Z,,0,0,09000064814c46a2
FDA-2013-P-1612-0010,FDA,FDA-2013-P-1612,Acknowledgement Letter from FDA/DDM to Lee Robertson,Other,Citizen Petition,2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,,2014-10-01T12:41:41Z,,0,0,09000064814c46a3
FDA-2013-P-1612-0002,FDA,FDA-2013-P-1612,Citizen Petition from Bruce G. Holland,Other,Citizen Petition,2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,2014-06-11T03:59:59Z,2015-09-23T13:24:51Z,,0,0,09000064814ba9c5
FDA-1994-V-0006-0005,FDA,FDA-1994-V-0006,"FDA/CDRH Response to Surefire, LLC - Approval of Variance",Other,Approval for Variance (VRA),2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,,2013-12-17T14:22:03Z,,0,0,09000064804fc5a2
FDA-2013-P-1612-0001,FDA,FDA-2013-P-1612,Acknowledgement Letter from FDA/DDM to Bruce Holland,Other,Acknowledgement Letter/Receipt,2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,,2015-03-25T13:25:52Z,,0,0,09000064814ba9cc
FDA-1994-V-0006-0006,FDA,FDA-1994-V-0006,Acknowledgement Letter to Laser Products,Other,Acknowledgement Letter/Receipt,2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,,2013-12-17T14:22:11Z,,0,0,09000064814c3399
FDA-1994-V-0006-0004,FDA,FDA-1994-V-0006,FDA/CDRH Response to Laser Products - Approval of Variance,Other,Approval for Variance (VRA),2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,,2013-12-17T14:21:51Z,,0,0,09000064804fc5a0
FDA-2007-P-0346-0053,FDA,FDA-2007-P-0346,"Richard Sauerheber, Ph.D. - Supplement",Other,Supplement (SUP),2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,,2013-12-17T19:41:19Z,,0,0,090000648136882c
FDA-2013-P-1612-0014,FDA,FDA-2013-P-1612,Acknowledgement Letter from FDA/DDM to Edith Hoechst,Other,Acknowledgement Letter/Receipt,2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,,2014-10-01T13:01:22Z,,0,0,09000064814c46af
FDA-2013-P-1612-0007,FDA,FDA-2013-P-1612,Citizen Petition from Michael L. Everts,Other,Citizen Petition,2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,2014-06-13T03:59:59Z,2015-09-23T13:26:40Z,,0,0,09000064814c4583
FDA-2013-P-1612-0004,FDA,FDA-2013-P-1612,Acknowledgement Letter from FDA/DDM to Lisa Hoechst,Other,Acknowledgement Letter/Receipt,2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,,2014-10-01T12:12:28Z,,0,0,09000064814c4580
FDA-2013-P-1612-0008,FDA,FDA-2013-P-1612,Acknowledgement Letter from FDA/DDM to Michael L. Everts,Other,Acknowledgement Letter/Receipt,2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,,2014-10-01T12:31:03Z,,0,0,09000064814c46a1
FDA-1994-V-0006-0002,FDA,FDA-1994-V-0006,Laser Products - Application for Variance,Other,Application for Variance (VAR),2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,,2013-12-17T14:21:31Z,,0,0,09000064804fc59c
FDA-2013-P-1612-0005,FDA,FDA-2013-P-1612,"Citizen Petition from Thomas Ma, M. D., Ph. D.",Other,Citizen Petition,2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,2014-06-12T03:59:59Z,2015-09-23T13:25:35Z,,0,0,09000064814c4581
FDA-1994-V-0006-0003,FDA,FDA-1994-V-0006,FDA/CDRH Response to Laser Products - Approval of Variance,Other,Approval for Variance (VRA),2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,,2013-12-17T14:21:43Z,,0,0,09000064804fc59f
FDA-2011-P-0297-0006,FDA,FDA-2011-P-0297,FDA/CDER Response to Public Citizen's Health Research Group - Petition Denial,Other,Denial,2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,,2013-12-17T12:29:00Z,,0,0,09000064814c44e2
FDA-2013-P-1612-0006,FDA,FDA-2013-P-1612,"Acknowlwdgement Letter from FDA/DDM to Thomas Ma, M. D., Ph. D.",Other,Acknowledgement Letter/Receipt,2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,,2015-03-25T13:15:09Z,,0,0,09000064814c4582
FDA-2013-P-1612-0041,FDA,FDA-2013-P-1612,Acknowledgement Letter from FDA/DDM to Carl D. Overton,Other,Acknowledgement Letter/Receipt,2013-12-16T05:00:00Z,2013,12,2013-12-16T05:00:00Z,,2014-10-01T14:11:56Z,,0,0,09000064814c46b3
FDA-2013-P-1612-0047,FDA,FDA-2013-P-1612,"Acknowledgement Letter from FDA/DDM to David B. Shirley, D. V. M.",Other,Acknowledgement Letter/Receipt,2013-12-16T05:00:00Z,2013,12,2013-12-16T05:00:00Z,,2014-10-01T14:29:54Z,,0,0,09000064814c46c5
FDA-2013-P-1612-0056,FDA,FDA-2013-P-1612,"Citizen Petition from Tom Hitchcock, R. D.",Other,Citizen Petition,2013-12-16T05:00:00Z,2013,12,2013-12-16T05:00:00Z,2014-06-16T03:59:59Z,2015-09-23T13:35:24Z,,0,0,09000064814c46ef